Arcturus Therapeutics Holdin

Stocks Under $10 Biotech Stocks Healthcare Stocks

$6.72

-0.10 (-1.47%)

As of Jul 4, 2:08 AM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 14 78%

Hold 4 22%

Sell 0 0%

Price Target

Analyst Price Target +293.0% upside

Low Target $16.23

Average Target $26.41

High Target $33.18

Current Price $6.72

Current
$6.72

Target
$26.41

$16.23 $26.41 avg $33.18

Scenario Analysis

Bear Case

$16.23

141.5%

Low target

Base Case

$26.41

+293.0%

Avg target

Bull Case

$33.18

+393.8%

High target

Risk/Reward

2.8x

Favorable

Price in Context

52-Week High

$24.17

-72.2% from high

52-Week Low

$5.85

+14.9% from low

Target vs 52W High

$26.41

+9.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	-1.3%
AMGN Amgen Inc	Hold	44	50%	$190.87	-49.0%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+176.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-17.0%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-88.3%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-67.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.7%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-48.8%